SUBSCRIBE
SUBSCRIBE
News   FDA

Astellas Pharma Inc. Wins Japan Approval for New Transplant Drug

July 17, 2008 | 
1 min read
TOKYO, July 17 (Reuters) - Astellas Pharma Inc said on Thursday it had won approval to sell a new version of its key transplant drug in Japan, the second major region where it has gained approval although it is facing delays in the United States.
FDA Approvals Asia
Astellas Pharma US, Inc.
MORE ON THIS TOPIC
Set your goals is shown using the collage with aim and the hand. Business targeting, aiming, focus concept and way to achieve a goal
Rare diseases
Cycle Wins First FDA Nod for Ultra-Rare Genetic Disease
June 20, 2025
 · 
1 min read
 · 
Tristan Manalac
A pill with the Amercan and Chinese flag wrapped around it
Government
FDA Freezes Trials Shipping Cells to China, ‘Other Hostile Countries’
June 20, 2025
 · 
2 min read
 · 
Tristan Manalac
A woman speaking into a microphone while standing behind a lectern
Government
Nicole Verdun Exits FDA as CBER Director Vinay Prasad ‘Consolidates Power’
June 20, 2025
 · 
3 min read
 · 
Dan Samorodnitsky
Gilead's headquarters in Silicon Valley
FDA
Gilead Wins Historic Approval for Twice-Yearly HIV Drug
June 18, 2025
 · 
2 min read
 · 
Dan Samorodnitsky